Changes in the liver transplant evaluation process during the early COVID-19 era and the role of telehealth

Table 5 Predictors of pre-transplant (pre- or waitlist) mortality, outpatients only, coronavirus disease 2019 era

	COVID era	P value
Hepatology liver transplant evaluation - telehealth	0.50 (0.19-1.33)	0.17
Race/ethnicity (ref: White)
Hispanic	2.81 (1.01-7.79)	0.05
Asian	0.52 (0.09-2.90)	0.45
Other	Inf
Insurance (ref: Private)
Medicare	1.20 (0.41-3.54)	0.74
Medi-cal	0.43 (0.11-1.63)	0.22
Distance to Stanford Hospital (per 50 miles)	0.73 (0.49-1.08)	0.12
MELD-Na at evaluation (per unit increase)	1.00 (0.93-1.08)	0.91

COVID: Coronavirus disease; MELD-Na: Model for end-stage liver disease with sodium.